The US FDA warns users of smartphone-linked diabetes devices like CGMs and insulin pumps of potential health risks due to missed critical alerts. Issu ...

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

The FDA issued an alert warning diabetes patients and caregivers about potential issues with smartphone alerts for continuous glucose monitors.